The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant. - Suthar MS; Manning KE; Ellis ML; Jain S; Bechnak K; Vander Velden J; Laboune F; Henry AR; Godbole S; Kim S; Sahoo MK; Paredes I; et al. (The Lancet. Infectious diseases, 2025)